Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Javier Cebollero"'
Autor:
Daniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, María Villalba-Esparza, Beatriz Moreno, Ashwathi Puravankara Menon, Alfonso Calvo, Javier Cebollero, Martin Barainka, Igor Ruiz de los Mozos, Carlos Huesa-Berral, Fernando Pastor
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-24 (2022)
Abstract Background The quality and quantity of tumor neoantigens derived from tumor mutations determines the fate of the immune response in cancer. Frameshift mutations elicit better tumor neoantigens, especially when they are not targeted by nonsen
Externí odkaz:
https://doaj.org/article/2e8fa14d44924374b4eb660bb5319ae9
Autor:
Mario M Soldevilla, Helena Villanueva, Naiara Martinez-Velez, Daniel Meraviglia-Crivelli, Marta M Alonso, Javier Cebollero, Ashwathi P Menon, Montserrat Puigdelloses, Fernando Pastor
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
In spite of the success of PD-1 blocking antibodies in the clinic their benefits are still restricted to a small fraction of patients. Immune-desert tumors and/or the highly immunosuppressive tumor milieu might hamper the success of PD-1/PD-L1 blocki
Externí odkaz:
https://doaj.org/article/a00e6e238c7a4f1aa23b2515f56475ec
Autor:
Helena Villanueva, Naiara Martinez-Velez, Marta M. Alonso, Fernando Pastor, Javier Cebollero, Mario Martínez Soldevilla, Daniel Meraviglia-Crivelli, Montserrat Puigdelloses, Ashwathi Puravankara Menon
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
In spite of the success of PD-1 blocking antibodies in the clinic their benefits are still restricted to a small fraction of patients. Immune-desert tumors and/or the highly immunosuppressive tumor milieu might hamper the success of PD-1/PD-L1 blocki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645ef83d39aa29f37ee2249cb2632a76
https://doi.org/10.1080/2162402x.2018.1450711
https://doi.org/10.1080/2162402x.2018.1450711
Autor:
Ashwathi Puravankara Menon, Helena Villanueva, Fernando Pastor, Marta Ruiz, Daniel Meraviglia-Crivelli, Álvaro Pejenaute, Beatriz Moreno, Pablo Sarobe, Teresa Lozano, Javier Cebollero, Maria Villalba, Diana Llopiz, Mario Martínez Soldevilla
Publikováno v:
Dadun. Depósito Académico Digital de la Universidad de Navarra
instname
Molecular Therapy
instname
Molecular Therapy
Cytotoxic T lymphocyte-associated protein 4 (CTLA-4) blockade therapy is able to induce long-lasting antitumor responses in a fraction of cancer patients. Nonetheless, there is still room for improvement in the quest for new therapeutic combinations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb4c152edda1a6d16efebed712c455a